Levi & Korsinsky is investigating the Board of Directors of American Medical Systems Holdings, Inc. (“AMS” or the “Company”) (Nasdaq: AMMD) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Endo Pharmaceuticals Holdings, Inc. (Nasdaq: ENDP). Under the terms of the transaction, AMS shareholders will receive $30 in cash per share of AMS stock they own. The transaction has a total value of approximately $2.9 billion, including the assumption of $312 million in AMS debt.
Click here to learn how to join the action: http://www.zlk.com/american-medical-systems-ammd.html, or call: 877-363-5972.
The investigation concerns whether the AMS Board of Directors breached their fiduciary duties to AMS stockholders by failing to adequately shop the Company before entering into this transaction and whether Endo Pharmaceuticals Holdings, Inc. is underpaying for AMS shares, thus unlawfully harming AMS stockholders.
If you own common stock in AMS and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/american-medical-systems-ammd.html.Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.